Delivery Order SPE2DB20D3505-SPE2DB26FYBYB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a ceiling value of $1,801.80 and an ultimate completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $2,700.77. This is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was awarded on a non-competitive basis as part of a broader procurement relationship between DLA and the...
- The Defense Logistics Agency awarded a $4,740.99 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml). This competitively awarded, firm fixed-price delivery order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. The contract carries no set-aside designation, reflecting AmerisourceBergen's competitive standing among...
- The Defense Logistics Agency awarded a $1,865.83 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen injectors on May 6, 2025, with completion scheduled for May 7, 2025. This firm fixed-price delivery order is non-set-aside and represents a continuation of pharmaceutical supply under AmerisourceBergen's existing contract vehicle with DLA. The product will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $1,201.20 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors. This firm fixed price, non-set-aside contract is scheduled for completion by October 23, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's larger pharmaceutical supply framework with the federal...
- The Defense Logistics Agency awarded a $5,648.01 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pen injectors with an ultimate completion date of August 27, 2025. This non-set-aside contract represents a single delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The place...
- The Defense Logistics Agency (DLA) awarded a $4,413.01 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 11, 2025, with completion scheduled for August 12, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within the pharmaceutical distribution portfolio that AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,654.56 for Trulicity 1.5 mg/0.5 ml pen injectors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed-price contract, executed without a set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $26,135.43 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors on September 2, 2025, with completion expected by September 3, 2025. This contract is issued under a firm fixed-price arrangement with no set-aside designation, representing a competitively awarded delivery order. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB26FYBYBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,502.55 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on October 24, 2025, with completion expected by October 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an existing indefinite delivery contract. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceuticals and medical supplies to military healthcare systems worldwide. Trulicity, a diabetes medication, exemplifies the specialized pharmaceutical products AmerisourceBergen delivers through its federal contract portfolio to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/24/25 |